Novartis Collaborates with ProFound Therapeutics to Develop Cardiovascular Therapies
By Amit Kaushik
Pharma Deals Review: Vol 2025 Issue 7 (Table of Contents)
Published: 18 Jul-2025
DOI: 10.3833/pdr.v2025.i7.2957 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to bolster its cardiovascular pipeline, Novartis has entered into a collaboration agreement with ProFound Therapeutics aimed at advancing the discovery and development of next-generation treatments for cardiovascular diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS